Back to search results

Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)

Abroad (travel likely)Recruiting

Conditions

Neuroendocrine Tumors · Neuroendocrine Neoplasm · Neuroendocrine Tumor Grade 1 · Neuroendocrine Tumor Grade 2 · Neuroendocrine Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Andrea M Isidori, Rome, Italy, Italy

    Contact: Study coordinator (Andrea M Isidori, MD, PhD) · andrea.isidori@uniroma1.it · 00390649970540
    Contact: Principal Investigator (Andrea M Isidori, MD, PhD)
    Elisa Giannetta, MD, PhD (Sub-investigator)
    Antongiulio Faggiano, MD, PhD (Sub-investigator)
    Mary Anna Venneri, PhD (Sub-investigator)
    Maria Grazia Tarsitano, MD, PhD (Sub-investigator)
    Giulia Puliani, MD (Sub-investigator)
    Tiziana Feola, MD (Sub-investigator)
    Franz Sesti, MD (Sub-investigator)
    Francesca Sciarra, PhD (Sub-investigator)
Study leads

  • Andrea M Isidori, MD, PhD

    Principal Investigator

    Department of Experimental Medicine, Sapienza University of Rome

View source on ClinicalTrials.gov(opens in a new tab)